Waters Corporation shares fall 1.54% intraday after Thermo Fisher completes acquisition of Solventum's Purification & Filtration business.

Waters Corporation declined 1.54% intraday, with recent news indicating that Thermo Fisher Scientific Inc. has completed its acquisition of the Purification & Filtration business of Solventum for approximately $4.0 billion in cash. This acquisition strengthens Thermo Fisher’s bioproduction offerings with advanced filtration technologies, potentially impacting Waters Corporation's market position. Additionally, Waters Corporation is advancing commercialization with new contracts, installations, and manufacturing expansion, which may not have been enough to offset the negative impact of the acquisition news.